Profile data is unavailable for this security.
About the company
The Calmer Co. International Limited is a health and wellness company with operations in Australia, Fiji, and the USA. The Company produces natural products to reduce anxiety, promote relaxation, improve sleep, and support sports recovery and performance. The company works with farmers to source high quality kava and hemp that is processed into active extracts for business to business (B2B) sales or into finished products across a house of brands. The Company’s brands include Fiji Kava, Taki Mai, and Danodan Hempworks. Its Taki Mai and Fiji Kava brands are focused on expanding the distribution of kava throughout global markets to provide a natural alternative to alcohol and to small molecule sleep and antianxiety prescription medicines. Its Danodan brand offers a patented range of USDA certified organic tinctures, and soon topicals, sold throughout the USA and online for relaxation, sleep, and recovery.
- Revenue in AUD (TTM)2.46m
- Net income in AUD-4.50m
- Incorporated2014
- Employees--
- LocationCalmer Co International Ltd96 Victoria Street, West EndBRISBANE 4101AustraliaAUS
- Phone+61 86489-1600
- Fax+61 86489-1601
- Websitehttps://www.thecalmerco.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epsilon Healthcare Ltd | 7.21m | -5.93m | 7.21m | -- | -- | 0.7868 | -- | 0.9994 | -0.0198 | -0.0198 | 0.0241 | 0.0305 | 0.3839 | 17.94 | 2.73 | -- | -31.54 | -35.68 | -46.30 | -41.11 | 37.99 | 26.88 | -82.17 | -197.56 | 0.5237 | -9.28 | 0.2329 | -- | 29.36 | 30.99 | -43.77 | -- | 8.14 | -- |
| Althea Group Holdings Ltd | 28.70m | -20.99m | 7.70m | -- | -- | 0.5023 | -- | 0.2684 | -0.059 | -0.059 | 0.0796 | 0.0378 | 0.6181 | 2.47 | 5.53 | -- | -45.22 | -31.09 | -66.73 | -36.32 | 54.64 | 50.76 | -73.15 | -101.39 | 0.4899 | -46.55 | 0.2756 | -- | 22.43 | 335.18 | -13.21 | -- | -- | -- |
| Anatara Lifesciences Ltd | 0.00 | -1.75m | 8.87m | -- | -- | 6.09 | -- | -- | -0.014 | -0.014 | 0.00 | 0.0076 | 0.00 | -- | -- | -- | -103.15 | -59.64 | -115.72 | -66.52 | -- | -- | -- | -1,927.05 | -- | -- | 0.00 | -- | -- | -- | 20.10 | -- | -40.49 | -- |
| Nyrada Inc | 3.08m | -4.98m | 9.66m | -- | -- | 1.81 | -- | 3.13 | -0.0319 | -0.0319 | 0.0198 | 0.0294 | 0.3983 | -- | -- | -- | -64.37 | -64.90 | -71.93 | -84.66 | -- | -- | -161.62 | -380.62 | -- | -15,086.39 | 0.00 | -- | 42.54 | 229.09 | -96.52 | -- | -- | -- |
| Firebrick Pharma Ltd | 0.00 | -4.57m | 9.77m | -- | -- | 5.60 | -- | -- | -0.0266 | -0.0266 | 0.00 | 0.0089 | 0.00 | -- | -- | -- | -120.70 | -- | -136.04 | -- | -- | -- | -- | -- | 4.37 | -- | 0.00 | -- | -79.85 | -- | -79.18 | -- | -- | -- |
| Argent BioPharma Ltd | 1.32m | -17.02m | 13.80m | -- | -- | 7.67 | -- | 10.42 | -3.32 | -3.32 | 0.1003 | 0.0372 | 0.0813 | 0.7078 | 1.58 | -- | -105.32 | -111.29 | -345.98 | -171.05 | 21.87 | 32.52 | -1,295.20 | -632.42 | 0.6561 | -24.85 | 0.4104 | -- | -28.41 | 47.31 | -2.34 | -- | -16.20 | -- |
| Calmer Co International Ltd | 2.46m | -4.50m | 15.03m | -- | -- | -- | -- | 6.10 | -0.0083 | -0.0083 | 0.0039 | -0.0005 | 0.655 | 1.34 | 9.62 | -- | -119.81 | -139.15 | -231.33 | -198.55 | 36.03 | 30.26 | -182.94 | -388.81 | 0.482 | -9.36 | 1.22 | -- | -13.00 | 239.43 | 11.40 | -- | -- | -- |
| TrivarX Ltd | 20.81k | -3.74m | 16.45m | 4.00 | -- | 1.45 | -- | 790.65 | -0.0182 | -0.0182 | 0.00009 | 0.0249 | 0.0023 | -- | -- | -- | -42.02 | -41.56 | -47.15 | -50.51 | 100.00 | 92.74 | -17,949.78 | -334.16 | -- | -147.21 | 0.0072 | -- | -4.69 | -18.06 | 75.85 | -- | -- | -- |
| Auscann Group Holdings Ltd | 2.05m | -9.44m | 18.02m | 27.00 | -- | -- | -- | 8.79 | -0.0213 | -0.0217 | 0.0043 | 0.0162 | 0.1674 | -- | 5.35 | -- | -77.15 | -39.85 | -78.72 | -40.73 | 100.59 | -- | -460.74 | -925.91 | -- | -23.16 | 0.00 | -- | 13.88 | 51.37 | 57.10 | -- | -- | -- |
| Acrux Ltd | 14.46m | -709.00k | 19.19m | 43.00 | -- | 3.39 | -- | 1.33 | -0.0024 | -0.0024 | 0.0502 | 0.0195 | 1.29 | -- | 4.86 | -- | -6.34 | -39.91 | -9.21 | -46.00 | 72.38 | -- | -4.90 | -132.53 | -- | -- | 0.2861 | -- | 133.74 | 28.29 | 92.23 | -- | -16.66 | -- |
| Immuron Ltd | 3.58m | -3.88m | 23.94m | 6.00 | -- | 1.36 | -- | 6.69 | -0.017 | -0.017 | 0.0157 | 0.0769 | 0.1664 | 0.6468 | 7.92 | 596,106.70 | -18.06 | -27.48 | -19.86 | -29.58 | 80.87 | 77.52 | -108.52 | -296.64 | 7.79 | -2.85 | 0.0023 | -- | 135.85 | -13.34 | -32.66 | -- | 3.27 | -- |
| Little Green Pharma Ltd | 25.63m | -8.15m | 29.87m | -- | -- | 0.3846 | -- | 1.17 | -0.0272 | -0.0272 | 0.0856 | 0.2574 | 0.2772 | 1.05 | 12.29 | -- | -8.82 | -- | -9.74 | -- | 53.18 | -- | -31.81 | -- | 1.39 | -18.90 | 0.0624 | -- | 29.07 | -- | 4.72 | -- | -- | -- |
